Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneLinda T. Vahdat, Joanne L. Blum, Dale E. Shuster et al.|Journal of Clinical Oncology|2009Cited by 245